Fertility preservation in rare ovarian tumors
Genomic analysis of low-grade serous ovarian carcinoma to identify key drivers and therapeutic vulnerabilities
MEK inhibitor resistance mechanisms and recent developments in combination trials
Multiomics Characterization of Low-Grade Serous Ovarian Carcinoma Identifies Potential Biomarkers of MEK Inhibitor Sensitivity and Therapeutic Vulnerability
Quaternary and beyond cytoreduction: An updated and expanded analysis
Tertiary cytoreduction for recurrent ovarian carcinoma: An updated and expanded analysis
Previous
Previous
2022
Next
Next